Completed

The Diagnosis, Pathogenesis and Treatment of Gyrate Atrophy of the Choroid and Retina

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Eye Diseases+4

+ Congenital, Hereditary, and Neonatal Diseases and Abnormalities

+ Uveal Diseases

See all eligibility criteria
How is the trial designed

Observational
Study Start: January 1978
See protocol details

Summary

Principal SponsorNational Eye Institute (NEI)
Last updated: March 4, 2008
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 1978

Actual date on which the first participant was enrolled.

Gyrate atrophy of the choroid and retina (GA) is a rare autosomal recessive chorioretinal degeneration characterized by myopia, cataract, varying degrees of night blindness, and progressive constriction of visual fields associated with chorioretinal atrophy resulting in blindness. The objectives of this protocol are threefold: Document the natural history of gyrate atrophy. Relate the clinical course to the gene defect to explore the genetic heterogeneity inherent in this disease. Assess the clinical course and laboratory findings of the effects of an arginine-deficient diet. The study population is patients with elevated plasma ornithine and absence of ornithine-delta-aminotransferase activity. This is a natural history study, with a nested intervention study, non-randomized, with the outcome parameters being psychophysical, electrophysiological and ophthalmoscopic examination.

NCT00001166
Principal SponsorNational Eye Institute (NEI)
Last updated: March 4, 2008
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

65 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Eye DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesUveal DiseasesEye Diseases, HereditaryChoroid DiseasesGenetic Diseases, InbornGyrate Atrophy

Criteria

INCLUSION CRITERIA: Patients must have hyperornithemia and a deficiency of OAT activity to enter the study.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

National Eye Institute (NEI)

Bethesda, United StatesOpen National Eye Institute (NEI) in Google Maps
CompletedOne Study Center